TY - JOUR

T1 - Carbon monoxide inhalation induces headache but no migraine in patients with migraine without aura

AU - Ghanizada, Hashmat

AU - Arngrim, Nanna

AU - Schytz, Henrik Winther

AU - Olesen, Jes

AU - Ashina, Messoud

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Introduction: Carbon monoxide is an endogenously produced signaling gasotransmitter known to cause headache and vasodilation. We hypothesized that inhalation of carbon monoxide would induce migraine-like attacks in migraine without aura patients. Methods: In a randomized, double-blind, placebo-controlled crossover design, 12 migraine patients were allocated to inhalation of carbon monoxide (carboxyhemoglobin 22%) or placebo on two separate days. Headache and migraine characteristics were recorded during hospital (0–2 hours) and post-hospital (2–13 hours) phases. Results: Six patients (50%) developed migraine-like attacks after carbon monoxide compared to two after placebo (16.7%) (p = 0.289). The median time to onset of migraine-like attacks after carbon monoxide inhalation was 7.5 h (range 3–12) compared to 11.5 h (range 11–12) after placebo. Nine out of 12 patients (75%) developed prolonged headache after carbon monoxide. The area under the curve for headache score (0–13 hours) was increased after carbon monoxide compared with placebo (p = 0.033). Conclusion: Carbon monoxide inhalation did not provoke more migraine-like attacks in migraine patients compared to placebo, but induced more headache in patients compared to placebo. These data suggest that non-toxic concentrations of carbon monoxide had low potency in migraine induction and that the carbon monoxide inhalation model is not suitable to study migraine.

AB - Introduction: Carbon monoxide is an endogenously produced signaling gasotransmitter known to cause headache and vasodilation. We hypothesized that inhalation of carbon monoxide would induce migraine-like attacks in migraine without aura patients. Methods: In a randomized, double-blind, placebo-controlled crossover design, 12 migraine patients were allocated to inhalation of carbon monoxide (carboxyhemoglobin 22%) or placebo on two separate days. Headache and migraine characteristics were recorded during hospital (0–2 hours) and post-hospital (2–13 hours) phases. Results: Six patients (50%) developed migraine-like attacks after carbon monoxide compared to two after placebo (16.7%) (p = 0.289). The median time to onset of migraine-like attacks after carbon monoxide inhalation was 7.5 h (range 3–12) compared to 11.5 h (range 11–12) after placebo. Nine out of 12 patients (75%) developed prolonged headache after carbon monoxide. The area under the curve for headache score (0–13 hours) was increased after carbon monoxide compared with placebo (p = 0.033). Conclusion: Carbon monoxide inhalation did not provoke more migraine-like attacks in migraine patients compared to placebo, but induced more headache in patients compared to placebo. These data suggest that non-toxic concentrations of carbon monoxide had low potency in migraine induction and that the carbon monoxide inhalation model is not suitable to study migraine.

KW - Carbon monoxide

KW - gasotransmitter

KW - hypoxia

KW - migraine

KW - nitric oxide

UR - http://www.scopus.com/inward/record.url?scp=85044028031&partnerID=8YFLogxK

U2 - 10.1177/0333102418765771

DO - 10.1177/0333102418765771

M3 - Journal article

C2 - 29540069

AN - SCOPUS:85044028031

VL - 38

SP - 1940

EP - 1949

JO - Cephalalgia

JF - Cephalalgia

SN - 0800-1952

IS - 13

ER -